Reports

Genome Engineering-EMEA Market Status and Trend Report 2019-2025

Id : 10328 Category : BBC Date : 6-Apr-19 Format : PDF Pages : 155
Report Summary

Genome Engineering-EMEA Market Status and Trend Report 2019-2025 offers a comprehensive analysis on Genome Engineering industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole EMEA and Regional Market Size of Genome Engineering 2013-2017, and development forecast 2018-2023
Main market players of Genome Engineering in EMEA, with company and product introduction, position in the Genome Engineering market
Market status and development trend of Genome Engineering by types and applications
Cost and profit status of Genome Engineering, and marketing status
Market growth drivers and challenges

The report segments the EMEA Genome Engineering market as:

EMEA Genome Engineering Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2019-2025):
Europe
Middle East
Africa

EMEA Genome Engineering Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2019-2025):
CRISPR
TALEN
ZFN
Antisense
Other Technologies

EMEA Genome Engineering Market: Application Segment Analysis (Consumption Volume and Market Share 2019-2025; Downstream Customers and Market Analysis)
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
Other Applications

EMEA Genome Engineering Market: Players Segment Analysis (Company and Product introduction, Genome Engineering Sales Volume, Revenue, Price and Gross Margin):
Thermo Fisher Scientific, Inc.
Merck KGaA
Horizon Discovery Group PLC
Genscript USA Inc.
Sangamo Biosciences, Inc.
Integrated DNA Technologies, Inc.
Lonza Group Ltd.
New England Biolabs, Inc.
Origene Technologies, Inc.
Transposagen Biopharmaceuticals, Inc.

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.